The European Union granted Boston Scientific approval to market the firm’s LATITUDE cardiac patient monitoring system. Designed to provide remote control and interrogation of implanted AICD’s and CRT-D’s, a special radio communicator talks with the devices to check their and the patient’s status. Additionally, an optional scale and blood pressure monitor can supplement the data being transmitted to the physician for a more complete picture of patient’s cardiac health.
From Boston Scientific:
The LATITUDE system provides physicians actionable information that enables them to see changes in their patients’ cardiac health sooner than regularly scheduled follow-up visits. LATITUDE is the only remote cardiac device monitoring system to offer a wireless weight scale and blood pressure monitor, both of which are recommended by the European Society of Cardiology for the management of Class I heart failure patients.
The international version of the LATITUDE system is compatible with the Company’s wireless TELIGEN® implantable cardioverter defibrillator (ICD) and COGNIS® cardiac resynchronization therapy defibrillator (CRT-D), the world’s smallest and thinnest high-energy devices.
Press release: Boston Scientific Announces European Approval for Its LATITUDE® Patient Management System …
Product page: The LATITUDE® Patient Management system …
Flashbacks: Big Doctor is Watching You ; Boston Scientific Receives Approval for Two New Defibrillators